Loading...
Risk factors in multiple myeloma: is it time for a revision?
Although therapeutic strategies have been adapted to age and comorbidities for a long time, almost all multiple myeloma (MM) patients currently receive similar treatment, whatever their disease risk category. However, high-risk MM patients still constitute an unmet medical need and should benefit fr...
Saved in:
| Published in: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7808011/ https://ncbi.nlm.nih.gov/pubmed/33024991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004309 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|